Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 5 of 14 for:    Hoffmann-La Roche SMA

A Study of Risdiplam in Infants With Genetically Diagnosed and Presymptomatic Spinal Muscular Atrophy (Rainbowfish)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03779334
Recruitment Status : Recruiting
First Posted : December 18, 2018
Last Update Posted : September 24, 2019
Sponsor:
Information provided by (Responsible Party):
Hoffmann-La Roche

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 21, 2021
Estimated Study Completion Date : October 8, 2025